Skip to content

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

A Stanford professor unpacks some of the dynamics of the current drug pricing system and the potential effects of other approaches to this market.

It’s one of the hardest questions in medicine: Should hospitals ever stop spending money to avert certain preventable deaths?

It’s one of the hardest questions in medicine: Should hospitals ever stop spending money to avert certain preventable deaths?

Stanford's David Ouyang sifted through more than a million texts to find out if clinicians inadvertently endorse brand-name medications over less expensive generic alternatives.

Stanford's David Ouyang sifted through more than a million texts to find out if clinicians inadvertently endorse brand-name medications over less expensive generic alternatives.

On Friday, KQED’s Forum offered a look at Medicare and Medicaid to mark the programs' 50-year anniversary. Stanford health policy researcher Laurence Baker, PhD, participated in the discussion, which covered …

A New York Times review called Steven Brill's book, America's Bitter Pill, "a thriller." Brill's tome on the building of the Affordable Care Act (ACA), aka Obamacare, …

Published on